Why Beach, Bendigo and Adelaide Bank, Opthea, and Paradigm shares are sinking

These ASX shares are having a bad start to the week…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.6% to 7,072.6 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are dropping:

Close up of a sad young woman reading about declining share price on her phone.

Image source: Getty Images

Beach Energy Ltd (ASX: BPT)

The Beach share price is down 12% to $1.63. Investors have been selling this energy producer's shares after its FY 2022 profits fell well short of expectations. Beach reported an underlying net profit after tax of $504 million. While this was up 39% year over year, it was nowhere near the consensus estimate of ~$546 million.

Bendigo and Adelaide Bank Ltd (ASX: BEN)

The Bendigo and Adelaide Bank share price is down over 8% to $9.89. This follows the release of the regional bank's FY 2022 results. Although the bank delivered a full year profit that was largely in line with expectations, its net interest margin (NIM) commentary appears to have disappointed investors. Goldman Sachs notes that "today's (NIM) update is disappointing."

Opthea Ltd (ASX: OPT)

The Opthea share price is down 9% to $1.27. This morning this clinical stage biopharmaceutical company announced that it has received binding commitments for a US$90 million placement to institutional investors. These funds were raised at a 17% discount of $1.15 per new share. The proceeds will be used to support phase 3 clinical trials of OPT-302.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm share price has crashed 27% lower to $1.45. This was also driven by a capital raising. The biopharmaceutical company is raising $66 million at $1.30 per new share. This represents a huge discount of 34.5% to the company's last close price of $1.985. Some of the proceeds will be used for Paradigm's phase 3 clinical program and new drug application-related activities.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo and Adelaide Bank Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Share Fallers

Why Bank of Queensland, Brainchip, Pilbara Minerals, and Yancoal shares are sinking today

These ASX shares are being hammered on Tuesday.

Read more »

a middle-aged woman holds up two fingers with a wide mouthed smile on her face and wide open eyes.
Share Fallers

'Top quality': Expert picks 2 ASX 200 shares to buy at a nice discount

These stocks are down but not out. One portfolio manager is convinced they'll make you richer in the long run.

Read more »

a group of business people sit dejectedly around a table, each expressing desolation, sadness and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Share Fallers

Why Atlantic Lithium, Arafura, Brainchip, and Core Lithium shares are falling

These ASX shares are starting the week in the red.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Atlantic Lithium, CBA, Piedmont Lithium, and Pilbara Minerals shares are dropping

These ASX shares are ending the week deep in the red.

Read more »

Woman looking at her smartphone and analysing share price.
Share Fallers

Golden buying opportunity for 2 ASX shares slashed last month: Celeste

Here's a pair of businesses that are going pretty strong but whose stock prices are in a dip, ready now…

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why 29Metals, BHP, Helia, and Rio Tinto shares are dropping today

Here's why these ASX shares are weighing on the market's performance on Thursday.

Read more »

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
Share Fallers

Why Nuix, Smartgroup, Ventia, and Woodside shares are dropping today

These ASX shares are having a tough time on the ASX boards on Wednesday.

Read more »

A woman looks distressed as she stares dramatically at her phone
Share Fallers

Why Brainchip, Lynas, Megaport, and Universal Store shares are dropping today

These ASX shares are having a tough time on Tuesday.

Read more »